Institute of Clinical Medicine, University of Oslo, Sognsvanssveien 21, 0372, Oslo, Norway.
Research Institute, Modum Bad Psychiatric Center, Modum Bad Research Institute, Badeveien 287, 3370, Vikersund, Norway.
BMC Psychiatry. 2022 Nov 30;22(1):745. doi: 10.1186/s12888-022-04381-5.
Patients with chronic depression (CD) typically have an early symptom onset, more psychiatric comorbidities, more treatment attempts, and more frequent and longer inpatient hospitalizations than patients with major depressive disorders. The main purpose of this study was to investigate the effectiveness of an intensive inpatient psychotherapy program for patients with chronic depression (CD). The primary research question was whether two intensive psychodynamic inpatient treatments, affect phobia therapy (APT) and VITA, were superior to an outpatient wait list condition, receiving treatment as usual (TAU), at completion of treatment. To investigate if a potential difference between the intensive treatment and the wait list control group was dependent on a specific psychotherapeutic model, the study contrasted two therapies with similar intensity, but different theoretical rationales.
Two hundred eighty patients with CD were included in a naturalistic study. Patients were assessed at four time points; assessment, start of therapy, end of therapy and 1-year follow-up. Three comparisons were performed with patients matched across groups; Intensive inpatient treatment program (APT + VITA) vs wait list during treatment, APT vs VITA during treatment and APT vs VITA during follow-up. The outcome measure was the BDI-II.
Intensive inpatient treatment program vs. wait list showed a significant difference in favor of the intensive treatment. No significant differences were found between APT and VITA during therapy or follow-up; but both groups had large effect sizes during treatment, which were maintained during follow-up.
The intensive inpatient psychotherapy program showed superior effect on chronic depression over an outpatient wait list condition receiving treatment as usual (TAU), but no significant differences were found between the two intensive inpatient psychodynamic treatments. The results provide support for the effectiveness of an intensive inpatient psychotherapy program in treatment of chronic and severe disorders, such as CD, which could be of benefit for policymakers and the health care sector as they are allocating recourses efficiently.
This study has been retrospectively registered on ClinicalTrials.gov (NCT05221567) on February 3rd, 2022.
慢性抑郁症(CD)患者的发病通常较早,共病精神障碍更多,治疗尝试更多,住院治疗的频率更高,住院时间更长。本研究的主要目的是调查密集型住院心理治疗方案对慢性抑郁症(CD)患者的有效性。主要研究问题是两种强化精神动力学住院治疗,即 affect phobia therapy(APT)和 VITA,是否优于门诊等候名单条件,即接受常规治疗(TAU),在治疗结束时。为了调查强化治疗和等候名单对照组之间的潜在差异是否取决于特定的心理治疗模式,该研究对比了两种强度相似但理论基础不同的治疗方法。
本研究纳入了 280 名 CD 患者,采用自然主义研究方法。患者在四个时间点进行评估:评估、开始治疗、治疗结束和 1 年随访。通过将组间患者匹配,进行了三项比较;强化住院治疗方案(APT+VITA)与治疗期间的等候名单、治疗期间的 APT 与 VITA 以及治疗期间的 APT 与 VITA 进行比较。疗效评估采用 BDI-II。
强化住院治疗方案与等候名单相比,强化治疗具有显著优势。治疗期间,APT 与 VITA 之间无显著差异,治疗后也无显著差异;但两组在治疗期间均有较大的效应量,且在随访期间得以维持。
强化住院心理治疗方案对慢性抑郁症的疗效优于门诊等候名单条件下的常规治疗(TAU),但两种强化精神动力学治疗方法之间无显著差异。研究结果支持强化住院心理治疗方案治疗慢性和严重疾病(如 CD)的有效性,这可能对政策制定者和卫生保健部门在有效分配资源方面有所帮助。
本研究于 2022 年 2 月 3 日在 ClinicalTrials.gov(NCT05221567)上进行了回顾性注册。